"We believe the outcomes of life-changing medical procedures shouldn’t be reliant on guesswork. The Stelect technology takes the guesswork out of coronary stent selection.”
- Elise Sutherland, CEO
A MESSAGE FROM OUR FOUNDER
Stelect is a multi award-winning Melbourne-based innovative medical device company developing a novel imaging solution to aid clinicians with the process of selecting stents for patients suffering from coronary heart blockage.
We're aiming to create better health outcomes for patients requiring stenting procedures as well as uplifting the outdated technology by introducing our novel and affordable imaging solution.
Our patented technology, an ultrasound imaging balloon catheter, has already received praise by interventional cardiologists as well as winning us numerous awards and recognition from the biggest MedTech and Venture Capitalist firms, globally.
Stelect is a Melbourne based innovative medical device company who believes that no procedure should be based on guesswork. We are passionate about ensuring patients have the best care and a positive outcome from their procedure.
Since formation in December of 2017, we have been focussed on achieving one goal, to create a medical device that removes the guesswork out of coronary stent selection, the most commonly performed procedure worldwide.
Everyday we take one step closer to achieving this goal. We invite you to follow along with us on this journey.
Percutaneous Coronary Intervention, or PCI, is the current method for assessing coronary artery blockages and selecting the optimal stent to implant to keep an artery open and blood flowing.
When performing PCI procedures, clinicians are limited to only an external view of the blocked artery. This gives clinicians limited information to make blockage evaluations and to determine the correct stent to implant.
The Stelect technology aims to change this. We are developing a pre-stent balloon catheter that utilises ultrasound technology to provide clinicians with a complete inside-out 3D visualisation of the blocked artery as well as in-depth data regarding blockage measurements and morphology, information vital to stent selection.
This technology will enable clinicians to base their stent selections on hard evidence and not guesswork.
OUR PARTNERS & SUPPORTERS
Stelect is proud to be in partnerships with the following Investment Firms, Research Institutes and Consulting Companies.
Get in touch with us today if you like to discuss our partnership opportunities.